Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) co-founder and CEO Brent Willis tells Proactive’s Stephen Gunnion that the company is on track to become a vertically integrated global leader in medical imaging contrast media by developing cost-effective and best-in-class products.
The company is also in the unique position of being the only pharmaceutical company globally to own natural barium and iodine resources within North America. Its ‘earth-to-bottle’ model will give it a highly-competitive cost advantage, Willis says.
With global contrast media shortages, he says Voyageur is in “the right space at the right time” to move forward.
#ProactiveInvestors #VoyageurPharmaceuticals #iodine #barium #FrancesCreek #TSX #OTC
